Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-12

Clinical Trial Update: Psilocybin-assisted CBT for Depression [Phase 1]

View source ↗

Summary

Phase 1 study evaluating psilocybin-assisted cognitive-behavioral therapy for Major Depressive Disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED